3D Bioprinting Market Analysis & Forecast

Market Insights

The 3D bioprinting market is likely to grow from USD 1.5 Billion in 2022 to reach USD 4.44 billion by 2028 at a healthy CAGR of 19.82% during the forecast period.

To get more information about this report, Register here.

What is 3D Bioprinting?

3D bioprinting is a form of additive manufacturing that utilizes 3D printing to fabricate biomedical parts which maximally imitate natural tissue characteristics. This printing utilizes the layer-by-layer method to deposit materials called bio-inks, to create tissue-like structures which are later used in tissue and medical engineering fields.

Key Players

Key players operating in the market are-

• 3D Systems Corporation (US)
• Aspect Biosystems Ltd (Canada)
• GeSIM GmbH (Germany)
• Allevi Inc. (US)
• Cyfuse Biomedical KK (Japan)
• Envision TEC GmbH (Germany)
• Organovo Holdings Inc. (US)
• RegenHU SA (Switzerland)
• Stratasys Ltd (US)
• REGEMAT 3D (Spain)

Market Dynamics

The limited number of organ donors and an increasingly senior population with chronic respiratory diseases are expected to boost the demand for 3D bioprinting.

Some other factors augmenting the market growth are-

• There is a growing need for organ transplants, with the use of 3D bioprinting, it may be possible to produce organs and tissues that are unique to a patient. The advancement of 3D bioprinting technology has seen a rise in financial support and research for the development of 3D bioprinting.
• The development of new 3D printing materials, software, and hardware has made it possible to print biological materials in greater detail and accuracy.
• The opportunity for 3D bioprinting to transform patient care has led to increasing interest in the healthcare sector. In addition, this has the potential to develop personalized medicine, and a reduction in animal experimentation is another benefit of the technology.
• Increasing Interest of Investors, private businesses, governments, and academic institutions have all made considerable investments in the 3D bioprinting sector. 

Moreover, a surge in public and private funding to support bioprinting research activities further offer immense growth opportunities to the industry players in the coming years.

COVID-19 Impact

Critical Questions Answered in the Report

• What are the key trends in the 3D bioprinting market?
• How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
• What is the impact of COVID-19 on the 3D bioprinting market?
• What are the key strategies adopted by the major vendors to lead in the 3D bioprinting market?
• What is the market share of the top vendors?

Segment Analysis

Application Trends

The widespread use of prescription tablets to treat a variety of chronic ailments is driving the expansion of the 3D bioprinting market. Furthermore, the increased need for medications and the cost-effective application of bio-drugs employing this technology is propelling the industry forward.

The demand for medical pills is rising as the number of pharmaceutical sector participants grows. Millions of individuals throughout the world utilize capsules and medical pills on a regular basis. As a result, this category is likely to increase at a rapid pace over the forecast period.

Click Here, to know the market segmentation details.

Component Trends

The market is classified into,3D Bioprinter, Biomaterial, and Scaffolds. 3D Bioprinters accounted for the largest market share during the forecast period. Factors such as technological advancements and growing demand for organ transplants are driving the growth of the market.

Technology Trends

The 3D bioprinting market is classified into inkjet-based, magnetic levitation, syringe-based, laser-based, and others. Inkjet-based segment share more than 35% in 2022, magnetic levitation segment is projected to expand with the fastest CAGR of nearly 14% during the forecast period. This is mainly ascribed to its ability to print complex living organs or tissues on the culture substrates with the help of biomaterials, such as bio-inks, which bolsters segment growth.

Regional Analysis

North America shares more than 30% in 2022 and is expected to lead throughout the forecast period and Asia Pacific is the fastest-growing market with shares of more than 20% in 2022. This is mainly attributed to a growing demand for 3D bioprinting as this technology has been reconnoitered for drug testing and organ transplantation. Also, the highly advanced healthcare industry, presence of major market players, robust research & development infrastructure, growing awareness of 3D Bioprinting, and technological developments in the region, further proliferate the regional market growth.

Know the high-growth countries in this report. Register Here.

Segmentation

The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The market is segmented into the following categories.

By Technology Type:

•  Inkjet-base
• Magnetic Levitation
• Syringe-base
•  Laser-base
• Others

By Component Type:

•  3D Bioprinter
•  Biomaterial
•  Scaffolds

By Application Type:

•  Medical
• Dental
• Biosensor
• Consumer/Personal Product Testing
• Bioink
• Food & Animal Product

By Region:

• North America (Country Analysis: the USA, Canada, and Mexico) 
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others).

Report Features

This report provides intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the dynamics and will enable strategic decision-making for the existing players and those willing to enter the market.

What Deliverables will you get in this report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.